The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,127

Coronavirus envelope protein: current knowledge

Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,149

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,678

Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques

Kwarteng, A., Asiedu, E., Sakyi, S. A., & Asiedu, S. O. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110914 · Cited by 29

Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Sharma, G., Saha, R. P., & Lee, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e5 · Cited by 26

BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?

Rajarshi, K., Chatterjee, A., & Ray, S. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100049 · Cited by 27

Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future

Fernández, E. C., & Zhu, L. Y. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14686 · Cited by 24

SARS‐CoV ‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice

Song, S., Kim, H., Jang, E. Y., Jeon, H.-M., Diao, H., Khan, M. R. I., Lee, M., Lee, Y. J., Nam, J., Kim, S., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13908 · Cited by 24

Advances in Targeting ACE2 for Developing COVID-19 Therapeutics

Suvarnapathaki, S., Chauhan, D., Nguyen, A., Ramalingam, M., & Camci‐Unal, G. (2022) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03094-w · Cited by 24

Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development

Corral‐Lugo, A., López‐Siles, M., López, D., McConnell, M. J., & Martín-Galiano, A. J. (2020) · Vaccines · doi:10.3390/vaccines8030397 · Cited by 22

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy

Piyush, R., Rajarshi, K., Khan, R., & Ray, S. (2020) · Open Biology · doi:10.1098/rsob.200174 · Cited by 22

Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach

Hisham, Y., Ashhab, Y., Hwang, S., & Kim, D. (2021) · Viruses · doi:10.3390/v13050787 · Cited by 22

The impact of the pandemic on the quality of education and the image of a university

Vinichenko, M. V., Vinogradova, M. V., Nikiporets-Takigawa, G. Y., & Rybakova, M. V. (2021) · XLinguae · doi:10.18355/xl.2021.14.01.02 · Cited by 21

Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China

Feng, X., Yin, J., Zhang, J., Hu, Y., Ouyang, Y., Qiao, S., Zhao, H., Zhang, T., Li, X., Zhang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614436 · Cited by 22

Potential SARS-CoV-2 vaccines: Concept, progress, and challenges

Hosseini, S. A., Zahedipour, F., Mirzaei, H., & Oskuee, R. K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107622 · Cited by 26

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

Jeda, A. S., Abbassi, S., Mousavizadeh, A., Esghaie, M., Bokharaei‐Salim, F., Jeddi, F., Shafaati, M., & Abdoli, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108232 · Cited by 22

Unmasking emerging issues in solid waste management: Knowledge and self-reported practices on the discarded disposable masks during the COVID-19 pandemic in the Philippines

Limon, M. R., Vallente, J. P. C., Cajigal, A. R. V., Aquino, M. U., Aragon, J. A., & Acosta, R. L. (2022) · Environmental Challenges · doi:10.1016/j.envc.2021.100435 · Cited by 20

In silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein

Mitra, D., Pandey, J., Jain, A. K., & Swaroop, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1869092 · Cited by 21

Development of an in silico multi-epitope vaccine against SARS-COV-2 by précised immune-informatics approaches

Zamane, S. A., Nobel, F. A., Jebin, R. A., Amin, M. A., Somadder, P. D., Antora, N. J., Hossain, M. I., Islam, M. J., Ahmed, K., & Moni, M. A. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100781 · Cited by 21

A Review of Different Vaccines and Strategies to Combat COVID-19

Sabitha, S., Shobana, N., Prakash, P., Padmanaban, S., Sathiyasree, M., Saigeetha, S., Chakravarthi, S., Uthaman, S., Park, I., & Samrot, A. V. (2022) · Vaccines · doi:10.3390/vaccines10050737 · Cited by 29

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management

Shoaib, M. H., Ahmed, F. R., Sikandar, M., Yousuf, R. I., & Saleem, M. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.576448 · Cited by 18

Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae

Ma, Z., Li, Z., Dong, L., Yang, T., & Xiao, S. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.06.003 · Cited by 18

Exploring the Potential Role of Theaflavin-3,3′-Digallate in Inhibiting Various Stages of SARS-CoV-2 Life Cycle: An In-Silico Approach

Jain, M., Anand, A., & Shah, A. P. (2022) · Chemistry Africa · doi:10.1007/s42250-022-00376-7 · Cited by 17

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2

Dawood, R. M., El-Meguid, M. A., Salum, G. M., El-Wakeel, K. H., Shemis, M. A., & Awady, M. K. E. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.12.006 · Cited by 17

COVID-19 Crisis: How Can Plant Biotechnology Help?

Shohag, M. J. I., Khan, F. Z., Tang, L. H., Wei, Y., He, Z. L., & Yang, X. (2021) · Plants · doi:10.3390/plants10020352 · Cited by 18

RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2

Feng, R., Xue, R., Liu, C., Li, G.-C., Deng, Y., Jin, Z., Liu, J.-Y., Zhang, S., Cheng, H., Guo, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03191-7 · Cited by 16

What We Need to Consider During and After the SARS-CoV-2 Pandemic

Valdivia-Granda, W., & Richt, J. A. (2020) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2020.2652 · Cited by 15

A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus

Kibria, K. M. K., Faruque, M. O., Islam, M. S. B., Ullah, H., Mahmud, S., Miah, M., & Saleh, A. A. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11988-x · Cited by 16

Nano‐therapeutic strategies to target coronavirus

Rauf, M. A., Tasleem, M., Bhise, K., Tatiparti, K., Sau, S., & Iyer, A. K. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200155 · Cited by 15

Coronavirus and COVID-19: the latest news and views from the scientific community about the new coronavirus and COVID-19

Coelho Paraguassu, E., Chen, H., Zhou, F., Xu, Z., & Wang, M. (2020) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2020v2n3p96-109 · Cited by 14

An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants

Siddique, F., Abbas, R. Z., Mansoor, M. K., Al-Ghamdi, E. S., Saeed, M., Ayaz, M., Rahman, M., Mahmood, M. S., Iqbal, A., Manzoor, M., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.586637 · Cited by 14

The COVID-19 puzzle: a global nightmare

Mahrosh, H. S., & Mustafa, G. (2021) · Environment Development and Sustainability · doi:10.1007/s10668-021-01224-3 · Cited by 14

Inside the story about the research and development of COVID-19 vaccines

Patel, S. P., Patel, G. S., & Suthar, J. V. (2021) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2021.10.2.154 · Cited by 13

CRISPR‐Cas13d effectively targets SARS‐CoV‐2 variants, including Delta and Omicron, and inhibits viral infection

Liu, Z. Z., Gao, X., Kan, C., Li, L., Zhang, Y., Gao, Y., Zhang, S., Zhou, L., Zhao, H., Li, M., et al. (2023) · MedComm · doi:10.1002/mco2.208 · Cited by 12

In silico design of Multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike proteinPreprint

Mitra, D., Pandey, J., Jain, A., & Swaroop, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.23.055467 · Cited by 11

Genomic Diversity and Evolution, Diagnosis, Prevention, and Therapeutics of the Pandemic COVID-19 DiseasePreprint

Hoque, M. N., Chaudhury, A., Akanda, M. A. M., Hossain, M. A., & Islam, T. (2020) · Preprints.org · doi:10.20944/preprints202004.0359.v1 · Cited by 13

Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity

Wu, G., Du, J., Yu, C., Fu, Z., Zhang, X., Wang, L., & Wang, J. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342349 · Cited by 10

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes

Akbay, B., Abidi, S. H., Ibrahim, M. A. A., Mukhatayev, Z., & Ali, S. (2021) · Vaccines · doi:10.3390/vaccines9070702 · Cited by 12

Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study

Demırhındı, H., Mete, B., Tanır, F., Kara, E., Kibar, F., Çeti̇ner, S., Candevir, A., & Akti, S. E. (2022) · Vaccines · doi:10.3390/vaccines10050687 · Cited by 12

RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics

Różański, M., Walczak‐Drzewiecka, A., Witaszewska, J., Wójcik, E. A., Guziński, A., Zimoń, B., Matusiak, R., Kazimierczak, J., Borowiec, M., Kania, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12179-4 · Cited by 12

A Review of the Progress of COVID-19 Vaccine Development

Ullah, S., Al-Sehemi, A. G., Klemeš, J. J., SAQIB, S., GONDAL, S. M. A., SAQIB, S., ARSHAD, A., Saqib, H., Mukhtar, A., IBRAHIM, M., et al. (2021) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.890089 · Cited by 12

A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19

Ahmed, S. I., Jamil, S., Ismatullah, H., Hussain, R., Bibi, S., Khandaker, M. U., Naveed, A., Idris, A. M., & Emran, T. B. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103561 · Cited by 11

A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2

Damodharan, K., Arumugam, G. S., Ganesan, S., Doble, M., & Thennarasu, S. (2021) · RSC Advances · doi:10.1039/d0ra09668g · Cited by 12

A CFD study of the transport and fate of airborne droplets in a ventilated office: The role of droplet-droplet interactions

Gomez-Flores, A., Hwang, G., Ilyas, S., & Kim, H. (2021) · Frontiers of Environmental Science & Engineering · doi:10.1007/s11783-021-1465-8 · Cited by 11

Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex

Kumawat, N., Tučs, A., Bera, S., Chuev, G. N., Valiev, M., Fedotova, M. V., Kruchinin, S. E., Tsuda, K., Sljoka, A., & Chakraborty, A. (2022) · Molecules · doi:10.3390/molecules27030799 · Cited by 11

Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants

Faizal, N. D. F. M., Ramli, N. A., Rani, N. N. I. M., Shaibie, N. A., Aarti, A., Poonsawas, P., Sharma, S. K., & Amin, M. C. I. M. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100855 · Cited by 10

New insights on possible vaccine development against SARS-CoV-2

Chaudhry, S. N., Hazafa, A., Mumtaz, M., Kalsoom, U., Abbas, S., Kainaat, A., Bilal, S., Zafar, N., Siddique, A., & Zafar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118421 · Cited by 10

Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins

Tajuelo, A., López‐Siles, M., Más, V., Pérez‐Romero, P., Aguado, J. M., Briz, V., McConnell, M. J., Martín-Galiano, A. J., & López, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062977 · Cited by 10

Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19)

Faizal, N. D. F. M., & Amin, M. C. I. M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122421 · Cited by 10

Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma

Han, I., Mumtaz, S., Ashokkumar, S., Yadav, D. K., & Choi, E. H. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110384 · Cited by 9

INSIGHT: a population scale COVID-19 testing strategy combining point-of-care diagnosis with centralised high-throughput sequencingPreprint

Wu, Q., Suo, C., Brown, T. P., Wang, T., Teichmann, S. A., & Bassett, A. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.01.127019 · Cited by 9

Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis

Ozsahin, D. U., Ameen, Z. S., Hassan, A. S., & Mubarak, A. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-55762-7 · Cited by 8

Potential use of 3-(trimethoxysilyl)propyldimethyl octadecyl ammonium chloride as an antimicrobial and antiviral agent for the disinfection of personal protective equipment

Kim, Y.-J., Youn, H.-N., Kim, J., Lee, D., Go, S.-H., Park, J.-E., Lee, S.-H., Noh, J.-Y., & Nahm, S. (2020) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2020.9.2.174 · Cited by 8

Accelerating SARS-CoV-2 Vaccine Development: Leveraging Novel Hybrid Deep Learning Models and Bioinformatics Analysis for Epitope Selection and Classification

Ameen, Z. S., Mostafa, H., Ozsahin, D. U., & Mubarak, A. S. (2023) · Processes · doi:10.3390/pr11061829 · Cited by 8

COVID-19 Review: An Epidemiological Perspective and Malaysian Scenario in Handling the Pandemic (January – May 2020)

Azhar, Z. I., Chen, X. W., Mohamad, M., Saman, M. S. A., Isa, M. R., & Ismail, N. B. (2020) · Journal of Clinical and Health Sciences · doi:10.24191/jchs.v5i1.9002 · Cited by 9

COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective?Preprint

Mogica, J. A. P., Garduño, V., & Torres, J. (2020) · medRxiv · doi:10.1101/2020.05.01.20087411 · Cited by 8

A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activitiesPreprint

Yin, D., Ling, S., Tian, X., Li, Y., Xu, Z., Jiang, H., Zhang, X., Wang, X., Shi, Y., Zhang, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.14.093054 · Cited by 8

The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachPreprint

Kibria, K. M. K., Islam, M. S. B., Ullah, H., & Miah, M. (2020) · doi:10.21203/rs.3.rs-21853/v1 · Cited by 8

Applying high throughput and comprehensive immunoinformatics approaches to design a trivalentsubunit vaccine forinduction of immune response against human emerging coronaviruses SARS-CoV, MERS-CoV and SARS-CoV2Preprint

Rahmani, A., Baee, M., Saleki, K., Moradi, S., & Nouri, H. R. (2020) · Research Square · doi:10.21203/rs.3.rs-92515/v1 · Cited by 8

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development

Oves, M., Ravindran, M., Rauf, M. A., Ansari, M. O., Zahin, M., Iyer, A. K., Ismail, I. M. I., Khan, M. A., & Palaniyar, N. (2020) · Pathogens · doi:10.3390/pathogens9120985 · Cited by 8

EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes

Ferreira, C. D. S., Martins, Y., Souza, R. C., & de Vasconcelos, A. T. R. (2021) · PeerJ · doi:10.7717/peerj.12548 · Cited by 7

Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines

Sun, C., Yuan, R., Xie, C., Sun, J., Fang, X., Hu, Y., Yu, X., Liu, Z., Zeng, M., & Kang, Y. (2022) · Journal of Virology · doi:10.1128/jvi.00383-22 · Cited by 7

Bilateral Vocal Fold Paralysis After COVID-19 mRNA Vaccination: A Case Report

Son, S. A., Kim, Y. J., Lim, S. Y., & Kim, H. B. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e201 · Cited by 7

Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review

Sakr, M. M., Elsayed, N. S., & El-Housseiny, G. S. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104809 · Cited by 9

Plant-based Vaccines

Sharma, P., Mondal, H., Mondal, S., & Majumder, R. (2021) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_185_21 · Cited by 7

Identifying Influencers On Twitter For Covid-19 Education And Vaccination Using Social Network Analysis

Yusuf, A. M., Saputro, M. R. G., & Maharani, W. (2021) · International Conference on Software Engineering and Computer Systems · doi:10.1109/icsecs52883.2021.00095 · Cited by 6

Development of SARS-CoV-2 Vaccine: Challenges and Prospects

Mahboob, T., Ismail, A. A., Shah, M. R., Rahmatullah, M., Paul, A. K., Pereira, M. D. L., Wiart, C., Wilairatana, P., Rajagopal, M. S., Dolma, K. G., et al. (2023) · Diseases · doi:10.3390/diseases11020064 · Cited by 6

The Relationship between Current COVID-19 and Indonesia Stock Market: Evidence from ARDL Model

Wardani, V. S., & Lahuddin, L. (2021) · Jurnal Ekonomi Pembangunan · doi:10.29259/jep.v19i1.13837 · Cited by 6

SECCIÓN VIII. Prevención y control de la infección por SARS-CoV-2/COVID-19. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud: Recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS. SEGUNDA EDICIÓN. 1 de agosto de 2020

Trujillo, C. H. S. (2020) · Infectio · doi:10.22354/in.v24i3.872 · Cited by 7

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series

Zhao, T., Shen, J., Zhu, Y., Tian, X., Wen, G., Wei, Y., Xu, B., Fu, C., Xie, Z., Xi, Y., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.875558 · Cited by 7

CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants

Bukur, T., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Hausmann, J., Rösler, T., Löwer, M., Schrörs, B., & Şahin, U. (2023) · Viruses · doi:10.3390/v15061391 · Cited by 5

Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines

Yang, H., Xie, Y., Lu, S., Sun, Y., Wang, K., Li, S., Wang, J., Liao, G., & Li, C. (2023) · Vaccines · doi:10.3390/vaccines11111681 · Cited by 5

Physicochemical properties-based hybrid machine learning technique for the prediction of SARS-CoV-2 T-cell epitopes as vaccine targets

Bukhari, S. N. H., Elshiekh, E., & Abbas, M. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.1980 · Cited by 5

Quasispecies analysis of the SARS-CoV-2 from representative clinical samples

Nyayanit, D. A., Yadav, P. D., Kharde, R., & Shete, A. M. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2251_20 · Cited by 5

An online longitudinal study about search index reflexing public attention of vaccinate against COVID-19

Ma, J., Luo, J., & Xu, M. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3064 · Cited by 4

Advances in mRNA vaccines for viral diseases

Huang, Y., Zhu, X., Guo, X., Zhou, Y., Liu, D., Mao, J., Xiong, Y., Deng, Y., & Gao, X. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28924 · Cited by 5

Prediction of B- and T-cell epitopes using in-silico approaches: a solution to the development of recombinant vaccines against COVID-19

Dariushnejad, H., Ghorbanzadeh, V., & Hashemzadeh, P. (2021) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.20.02652-x · Cited by 5

Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the COVID-19 VirusPreprint

Nair, D. T., & Narayanan, N. (2020) · doi:10.35543/osf.io/p48fa · Cited by 5

Neural Network-Based Ensemble Learning Model to Identify Antigenic Fragments of SARS-CoV-2

Bukhari, S. N. H., & Ogudo, K. A. (2024) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2024.3487149 · Cited by 4

Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

Abdullahi, I. N., Emeribe, A. U., Adekola, H. A., Abubakar, S. D., Dangana, A., Shuwa, H. A., Nwoba, S. T., Mustapha, J. O., Haruna, M., Olowookere, A. K., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1812313 · Cited by 5

Synopsis of Pharmotechnological Approaches in Diagnostic and Management Strategies for Fighting Against COVID-19

Azhar, A., Hassan, N., Singh, M., Alhosaini, K. A., & Kamal, M. A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210715154004 · Cited by 4

El papel de la nanociencia y la nanotecnología en el marco de la pandemia de COVID-19

Durán–Álvarez, J. C., Avelar, C. M., & Mejia-Almaguer, D. (2020) · Mundo Nano Revista Interdisciplinaria en Nanociencia y Nanotecnología · doi:10.22201/ceiich.24485691e.2021.27.69647 · Cited by 4

The impact of Covid-19 lockdown on socio-economic activities in Kaduna State, Nigeria

Yahaya, A. M., Montiliat, A., & Salahudeen, H. (2020) · Journal of Sustainable Tourism and Entrepreneurship · doi:10.35912/joste.v2i1.547 · Cited by 4

CAN BAICALEIN BECOME A NEW DRUG FOR COVID-19?

Patočka, J., Navrátilová, Z., Kuča, K., Olekšák, P., & Killi, U. K. (2021) · Military Medical Science Letters · doi:10.31482/mmsl.2021.020 · Cited by 4

PIJAT MERIDIAN UNTUK MENINGKATKAN IMUNITAS TUBUH DI ERA COVID-19 DI KELURAHAN GANJAR ASRI METRO

Anisa, L., Liza, I. N., Priyani, T., Wahyuni, M. S., & Fibrila, F. (2021) · Prosiding Penelitian Pendidikan dan Pengabdian 2021 · Cited by 4

On spatial molecular arrangements of SARS-CoV2 genomes of Indian patientsPreprint

Hassan, S. S., Moitra, A., Rout, R. K., Choudhury, P. P., Pramanik, P., & Jana, S. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.01.071985 · Cited by 4

Global Shock in Economic Activities: COVID-19 PandemoniumPreprint

Nwokolo, C. I., Ogbuagu, M. I., & Iwegbu, O. (2020) · doi:10.21203/rs.3.rs-20705/v1 · Cited by 4

Immunization with virus-like vesicle-based COVID-19 vaccine induces robust systemic and mucosal immunity

Yang, L., Yarovinsky, T. O., Pham, K., Xi, Y., Lu, P., Iwasaki, A., Rose, J. K., & Liu, C. (2025) · npj Vaccines · doi:10.1038/s41541-025-01260-4 · Cited by 3

Impact of SARS-CoV-2 on Aerobic and Anaerobic Capacity in Professional Ice Hockey Players

Roczniok, R., Terbalyan, A., Pietraszewski, P., Mikrut, G., Zielonka, H., Šťastný, P., Swinarew, A. S., Manilewska, D., Ornowski, K., Jabłoński, T., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103478 · Cited by 3

Detection of SARS-CoV-2 Neutralizing Antibodies in Vaccinated Pregnant Women and Neonates by Using a Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader

Chen, W., Lin, Y.-P., Cheng, C., Shen, C., Li, C., Wang, Y., Shih, T., Hong, C., Chang, T., & Shen, C. (2022) · Biosensors · doi:10.3390/bios12100891 · Cited by 3

Studi Vaccine Product-Related Reaction Pasca Pemberian Booster Vaksin Covid-19

Anggraeni, R., Setianingsih, S., & Darwati, L. E. (2022) · Jurnal Gawat Darurat · doi:10.32583/jgd.v4i2.667 · Cited by 3

Imunologia da Doença por Coronavírus-19 (COVID-19): Uma Perspetiva Para o Clínico, nos Primeiros 4 Meses da Emergência do SARS-CoV-2

Delgado, L., Boechat, J. L., & Chora, I. (2021) · Medicina Interna · doi:10.24950/rspmi/covid19/fmup/s/2020 · Cited by 3

COVID-19 Vaccines - Current State and Perspectives

Abdurakhmonov, I. Y. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101006 · Cited by 4

Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus‐2 proteome

Sadia, A., & Basra, M. A. R. (2020) · Drug Development Research · doi:10.1002/ddr.21710 · Cited by 3

INSIGHT: a scalable isothermal NASBA-based platform for COVID-19 diagnosis v1Preprint

Wu, Q., Suo, C., Brown, T., Wang, T., Teichmann, S. A., & Bassett, A. R. (2020) · doi:10.17504/protocols.io.bghsjt6e · Cited by 3

Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches

Huang, Z., Shi, H., Gong, H., Sun, Q., Yang, S., Zhang, Y., Shi, Z., Xia, Z., Huang, S., Yao, S., et al. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2905196 · Cited by 2

A GC–MS Method for Determination of β-Propiolactone Residues in Inactivated Covid-19 Vaccines

Mirjalili, S. Z., Tamiji, Z., Shirangi, M., & Amini, M. (2024) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmae049 · Cited by 2

A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19

Singh, S., & Jayaram, R. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.14 · Cited by 2

An Essencist Evaluation of Socio-Economic Impacts of Coronavirus Disease (COVID-19) Pandemic in Nigeria

Ekanem, S. A., Imarenezor, E. P. K., & Okolisah, C. P. (2020) · Mediterranean Journal of Social Sciences · doi:10.36941/mjss-2020-0057 · Cited by 2

Spotlight of Twenty First Century Betacoronaviruses

Pratheep, T., & Kumar, G. V. (2020) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2020.03.0736 · Cited by 1

SECCION X. Prevención y control de la infección por SARS – COV-2/COVID-19

Trujillo, C. H. S. (2021) · Infectio · doi:10.22354/in.v25i4.980 · Cited by 2

Sex differences in SARS-CoV-2 infections, anti-viral immunity and vaccine responses

Mohanty, A., Sawhney, A., Gupta, S., Rao, V. U. S., Govindaraj, P., Mohanty, S. K., & Jain, V. S. (2022) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.340567 · Cited by 2

Engaging African diaspora in the fight against vaccine hesitancy

Ateghang-Awankem, B., & Anchang, K. Y. (2020) · American journal of public health research · doi:10.12691/ajphr-9-1-4 · Cited by 2

Vaccines and Treatment Strategies for SARS-COV-2Preprint

Sarkar, A., & Maulik, U. (2020) · doi:10.31219/osf.io/3qzm2 · Cited by 2

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84

SARS-CoV-2 Leading Vaccine Candidates: Progress and Development

Amraiz, D., Fatima, M. T., & Navid, M. T. (2020) · Life and Science · doi:10.37185/lns.1.1.153 · Cited by 2

Targets and strategies for vaccine development against SARS-CoV-2

Malik, J. A., Mulla, A. H., Farooqi, T., Pottoo, F. H., Anwar, S., & Rengasamy, K. R. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111254 · Cited by 81

Vaccination strategies to combat novel corona virus SARS-CoV-2

Pandey, S. C., Pande, V., Sati, D., Upreti, S., & Samant, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117956 · Cited by 125